+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria



Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria



Antimicrobial Agents and ChemoTherapy 35(5): 819-823



Resistance to mercury was evaluated in 356 rapidly growing mycobacteria belonging to eight taxonomic groups. Resistance to inorganic Hg2+ ranged from 0% among the unnamed third biovariant complex of Mycobacterium fortuitum to 83% among M. chelonae-like organisms. With cell extracts and 203Hg(NO3)2 as the substrate, mercuric reductase (HgRe) activity was demonstrable in six of eight taxonomic groups. HgRe activity was inducible and required NADPH or NADH and a thiol donor for optimai activity. Species with HgRe activity were also resistant to organomercurial compounds, including phenylmercuric acetate. Attempts at intraspecies and intragenus transfer of HgRe activity by conjugation or transformation were unsuccessful. Mercury resistance is common in rapidly growing mycobacteria and appears to function via the same inducible enzyme systems already defined in other bacterial species. This system offers potential as a strain marker for epidemiologic investigations and for studying genetic systems in rapidly growing mycobacteria.

(PDF emailed within 0-6 h: $19.90)

Accession: 040679168

Download citation: RISBibTeXText

PMID: 1854163

DOI: 10.1128/AAC.35.5.819


Related references

Mercuric reductase hgre activity in clinical isolates of rapidly growing mycobacteria rgm. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 135, 1988

Tetracycline resistance and presence of tetracycline resistance determinants tet(V) and tap in rapidly growing mycobacteria from agricultural soils and clinical isolates. Microbes and Environments 27(4): 413-422, 2013

In vitro activity of linezolid against isolates of rapidly growing mycobacteria. Abstracts of the General Meeting of the American Society for Microbiology 100: 654, 2000

Mercury (II) removal by resistant bacterial isolates and mercuric (II) reductase activity in a new strain of Pseudomonas sp. B50A. New Biotechnology 33(1): 216-223, 2016

Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria. Clinical Microbiology and Infection 15(10): 919-923, 2009

In vitro activity of a novel des-fluoro quinolone BMS-284756 against rapidly growing mycobacteria and Nocardia isolates. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 175, 2001

In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates. Journal of Antimicrobial ChemoTherapy 50(1): 140-142, 2002

In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrobial Agents and ChemoTherapy 51(5): 1849-1851, 2007

Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria. International Journal of Antimicrobial Agents 34(5): 454-456, 2009

Mercury-resistance and mercuric reductase activity in Chromobacterium, Erwinia, and Bacillus species. Bulletin of Environmental Contamination and Toxicology 38(6): 1070-1075, 1987

In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. Australian Veterinary Journal 93(1-2): 40-45, 2015

In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: Resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates. APMIS 101(1): 27-32, 1993

Spectrum of disease due to rapidly growing mycobacteria. Reviews of Infectious Diseases 5(4): 657-679, 1983

Mercuric reductase activity in the adaptation to cationic mercury, phenyl mercuric acetate and multiple antibiotics of a gram-negative population isolated from an aerobic fixed-bed reactor. Journal of Applied Bacteriology 71(5): 439-444, 1991

Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet. Infectious Diseases 8(6): 390-398, 2008